Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Above averageTeleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We market and sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors.
In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR
Business segments
Q1 2026 · $548.3MThe company’s own SEC segment disclosure.
- Vascular Access$236.8M43%
- Interventional$204.7M37%
- Surgical$106.8M19%
Teleflex Incorporated (TFX) reported revenue of $570M in Q2 2026 (quarter ended June 30, 2026), up 29% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $100M (17% of revenue). For the full year FY2025, revenue was $1.99B (+17% year on year) and net income −$906M. Its largest product in 2026-Q1 was Vascular Access at $237M, 43% of the disclosed total, just ahead of Interventional at 37%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Medical Instruments & Supplies
Ranks #12 of 27 by Smart Score